QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 7 October 2008
doi: 10.1242/jcs.031898

This Article Figures Only Full Text Full Text (PDF) Supplementary Material All Versions of this Article: jcs.031898v1 121/21/3570    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mattila, E. Articles by Ivaska, J. Search for Related Content PubMed PubMed Citation Articles by Mattila, E. Articles by Ivaska, J. Social Bookmarking                         What's this?

The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling

¹ VTT Technical Research Centre of Finland, Medical Biotechnology, Turku FIN-20520, Finland
² Centre for Biotechnology, Turku University, Turku FIN-20520, Finland
³ MediCity Research Laboratory, Turku University, Turku FIN-20520, Finland

^* Author for correspondence (e-mail: johanna.ivaska{at}vtt.fi)

Accepted 28 July 2008

Vascular endothelial growth factor (VEGF) is a major angiogenic factor that triggers formation of new vessels under physiological and pathological conditions. However, the mechanisms that limit the VEGF responses in target cells and hence prevent excessive and harmful angiogenesis are not well understood. Here, our objective was to study whether T-cell protein tyrosine phosphatase (TCPTP, also known as PTN2), which we found to be expressed in human endothelial cells, could alter VEGF signalling by controlling phosphorylation of VEGFR2. We show that a TCPTP substrate-trapping mutant interacts with VEGFR2. Moreover, TCPTP dephosphorylates VEGFR2 in a phosphosite-specific manner, inhibits its kinase activity and prevents its internalization from the cell surface. We found that TCPTP activity is induced upon integrin-mediated binding of endothelial cells to collagen matrix. TCPTP activation was also induced by using cell-permeable peptides from the cytoplasmic tail of the collagen-binding integrin 1. Controlled activation of TCPTP results in inhibition of VEGF-triggered endothelial cell proliferation, angiogenic sprouting, chemokinesis and chemotaxis. We conclude that matrix-controlled TCPTP phosphatase activity can inhibit VEGFR2 signalling, and the growth, migration and differentiation of human endothelial cells.

Key words: T-cell protein tyrosine phosphatase (TCPTP), VEGF, VEGFR2, Endothelium, Integrin

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?